Home » Clinical Trials » Therapeutic Areas

Therapeutic Areas: Oncology | Nephrology | Urology | Family Medicine
Disease Category: Prostate Cancer
Location: United States, ND

Clinical Trial Details


Research Study Summary

Prostate Cancer


To demonstrate superiority in the overall survival of patients with progressive prostate cancer.

Patient Inclusion Criteria:

  • Confirmed diagnosis of prostate cancer, patients must have surgical or ongoing chemical castration, patients must have disease that has failed one prior docetaxel-based chemotherapy regimen for the treatment of metastatic disease, disease progression

Patient Exclusion Criteria:

  • Prior treatment with sunitinib and more than one prior chemotherapy regimen in the metastatic disease treatment setting, chemotherapy within 3 weeks of the date of the first dose.

To Learn more

CW ID: 163092
Date Last Changed: July 24, 2013

Clinical Trial Snapshot

Overall Status
Facility Type


Dr. Tom Davis, Director of Business Development
Legacy Pharma Research
601 N. 5th St.
Bismarck, ND 58501
Phone: 701-751-1128
Fax: 701-751-1131

View Map

Volunteer for this Trial

If you would like to learn more about participating in this research study, please email the trial contact using the form below. We value your privacy and your information will only be used by the research center to contact you regarding this study.

DISCLAIMER: CenterWatch does not conduct clinical research. CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies, contract research organizations, clinical research sites and other interested parties. This information is designed to help patients find clinical trials of interest and contact the research centers conducting the trials.